Sulfacytine

磺胺乙胞嘧啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfacytine
Drug Alias NameRenoquid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1975/09/12
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlenwood
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlenwood Inc
Active IndicationsN/A
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG